Doctor profile · Federal record
Dr. Stephen Pagkalinawan, MD
Infectious Disease Physician (CMS: Infectious Disease) · Infectious Disease Physician · Pediatrics Physician · Pediatrics Physician · Philadelphia, PA
- NPI 1750743720
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1427 Vine St
Philadelphia, PA 191021031
(215) 762-2530 - Mailing address
-
1845 Gerritt St
Philadelphia, PA 191464629
Credentials & registration
- NPI registered
- March 2016 — 10 yrs on file
- Profile last updated
- March 26, 2025
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State licenses (2)
- Pennsylvania #MD470539 · New Jersey #25MA11492300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750743720. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
70
Distinct HCPCS
3
Medicare allowed
$7,652
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 45 | 30 | $85 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 14 | 14 | $128 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 11 | 11 | $186 |
In context: peer comparison
Among 51 peers in Philadelphia Infectious Disease Physician, average services per provider: 65. This provider delivers 1.1× the peer median.Open Payments
Industry payments received
All-time total
$780
Transactions
27
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, INC. | 10 | $468.79 | |
| ViiV Healthcare Company | 16 | $285.08 | |
| Pharming Healthcare, INC. | 1 | $25.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
490
Patients
55
Total drug cost
$673,809
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 145 | 27 | $586,577 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 53 | 14 | $1,686 |
| Atorvastatin Calcium | Generic | 45 | 14 | $619 |
| Gabapentin | Generic | 34 | 0 | $702 |
| Lisinopril | Generic | 32 | 0 | $310 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 26 | 0 | $1,488 |
| Dovato (Dolutegravir Sodium/Lamivudine) | Brand | 25 | 0 | $74,362 |
| Rosuvastatin Calcium | Generic | 22 | 0 | $328 |
| Amlodipine Besylate-Benazepril (Amlodipine Besylate/Benazepril) | Brand | 21 | 0 | $278 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 17 | 0 | $6,718 |
Frequently asked questions
What is Dr. Stephen Pagkalinawan's medical specialty?
Dr. Stephen Pagkalinawan practices Infectious Disease Physician in Philadelphia, PA.
Where does Dr. Stephen Pagkalinawan practice?
Dr. Stephen Pagkalinawan practices at 1427 Vine St, Philadelphia, PA 191021031. Office phone: 2157622530.
What is Dr. Stephen Pagkalinawan's NPI?
Dr. Stephen Pagkalinawan's National Provider Identifier (NPI) is 1750743720, issued by NPPES.
Does Dr. Stephen Pagkalinawan accept Medicare assignment?
Yes. Dr. Stephen Pagkalinawan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Pagkalinawan commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.